BRAIN Biotech AG (ETR:BNN)
Germany · Delayed Price · Currency is EUR 2.670
+0.010 (0.38%)
Oct 16, 2026, 5:37 PM CET
BRAIN Biotech AG Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, BRAIN Biotech AG stock has a consensus rating of "Strong Buy" and an average price target of €5.75. The average 1-year stock price forecast is 115.36% higher than the current stock price, while the lowest is €5.00 (+87.27%) and the highest is €6.50 (+143.45%).
Price Target: €5.75 (+115.36%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BRAIN Biotech AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Financial Forecast
Revenue This Year
49.05M
from 50.22M
Decreased by -2.32%
Revenue Next Year
62.49M
from 49.05M
Increased by 27.40%
EPS This Year
-0.42
from -0.47
EPS Next Year
-0.40
from -0.42
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.